KRS
VRTX icon

Kentucky Retirement Systems’s Vertex Pharmaceuticals VRTX Stock Holding History

Kentucky Retirement Systems’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
19,299
+3,152
+20% +$1.47M 0.11% 220
2025
Q4 		$7.32M Hold
16,147
– – 0.2% 93
2025
Q3 		$6.32M Sell
16,147
-427
-3% -$178K 0.17% 106
2025
Q2 		$7.38M Sell
16,574
-1,085
-6% -$500K 0.22% 92
2025
Q1 		$8.56M Sell
17,659
-77
-0.4% -$35.9K 0.26% 80
2024
Q4 		$7.14M Sell
17,736
-245
-1% -$114K 0.21% 88
2024
Q3 		$8.36M Sell
17,981
-1,465
-8% -$704K 0.25% 77
2024
Q2 		$9.11M Sell
19,446
-124
-0.6% -$53.8K 0.26% 77
2024
Q1 		$8.18M Sell
19,570
-1,047
-5% -$443K 0.24% 84
2023
Q4 		$8.39M Buy
20,617
+52
+0.3% +$19.2K 0.26% 80
2023
Q3 		$7.15M Sell
20,565
-143
-0.7% -$50K 0.25% 88
2023
Q2 		$7.29M Buy
20,708
+381
+2% +$128K 0.24% 87
2023
Q1 		$6.4M Buy
20,327
+164
+0.8% +$49.2K 0.24% 94
2022
Q4 		$5.82M Buy
20,163
+88
+0.4% +$26.8K 0.23% 103
2022
Q3 		$5.81M Buy
20,075
+1,093
+6% +$314K 0.25% 87
2022
Q2 		$5.35M Buy
18,982
+2,755
+17% +$737K 0.23% 97
2022
Q1 		$4.24M Buy
16,227
+859
+6% +$204K 0.17% 121
2021
Q4 		$3.38M Buy
15,368
+111
+0.7% +$21.6K 0.14% 150
2021
Q3 		$2.77M Buy
15,257
+183
+1% +$35.7K 0.13% 155
2021
Q2 		$3.04M Sell
15,074
-606
-4% -$127K 0.14% 146
2021
Q1 		$3.37M Buy
15,680
+341
+2% +$74.9K 0.16% 132
2020
Q4 		$3.63M Buy
15,339
+149
+1% +$34.2K 0.19% 121
2020
Q3 		$4.13M Buy
15,190
+756
+5% +$209K 0.26% 82
2020
Q2 		$4.19M Sell
14,434
-3,128
-18% -$848K 0.29% 74
2020
Q1 		$4.18M Buy
17,562
+4,333
+33% +$994K 0.29% 77
2019
Q4 		$2.9M Buy
13,229
+58
+0.4% +$11.7K 0.21% 108
2019
Q3 		$2.23M Buy
13,171
+1,243
+10% +$220K 0.18% 137
2019
Q2 		$2.19M Buy
11,928
+751
+7% +$131K 0.19% 120
2019
Q1 		$2.06M Buy
11,177
+61
+0.5% +$11.3K 0.2% 114
2018
Q4 		$1.84M Buy
11,116
+233
+2% +$40.4K 0.2% 119
2018
Q3 		$2.1M Buy
10,883
+64
+0.6% +$11.4K 0.2% 114
2018
Q2 		$1.84M Sell
10,819
-2,431
-18% -$377K 0.19% 129
2018
Q1 		$2.16M Sell
13,250
-2,346
-15% -$383K 0.18% 130
2017
Q4 		$2.34M Buy
15,596
+303
+2% +$44.9K 0.17% 141
2017
Q3 		$2.33M Sell
15,293
-673
-4% -$101K 0.18% 138
2017
Q2 		$2.06M Buy
15,966
+38
+0.2% +$4.57K 0.15% 159
2017
Q1 		$1.74M Sell
15,928
-2,070
-12% -$182K 0.13% 181
2016
Q4 		$1.33M Sell
17,998
-939
-5% -$76.4K 0.09% 247
2016
Q3 		$1.65M Sell
18,937
-2,097
-10% -$198K 0.11% 224
2016
Q2 		$1.81M Sell
21,034
-1,602
-7% -$138K 0.12% 210
2016
Q1 		$1.8M Buy
22,636
+3,973
+21% +$359K 0.11% 220
2015
Q4 		$2.35M Buy
18,663
+1,876
+11% +$226K 0.17% 137
2015
Q3 		$1.75M Buy
16,787
+340
+2% +$43.7K 0.15% 160
2015
Q2 		$2.03M Buy
16,447
+153
+0.9% +$19.3K 0.17% 149
2015
Q1 		$1.92M Sell
16,294
-1,585
-9% -$190K 0.16% 163
2014
Q4 		$2.12M Sell
17,879
-643
-3% -$72.4K 0.16% 157
2014
Q3 		$2.08M Buy
+18,522
New +$1.76M 0.15% 159
2014
Q1 		$1.38M Buy
19,544
+245
+1% +$19.4K 0.1% 242
2013
Q4 		$1.43M Sell
19,299
-39
-0.2% -$2.72K 0.11% 220
2013
Q3 		$1.47M Buy
+19,338
New +$1.54M 0.12% 208

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Kentucky Retirement Systems's VRTX Position: Q1 2026 in Review

Kentucky Retirement Systems increased its Vertex Pharmaceuticals (VRTX) stake by 20% in Q1 2026, buying an estimated $1.47M and bringing the position to 19,299 shares worth $1.43M. The position accounts for 0.11% of the portfolio, ranked #220.

Kentucky Retirement Systems first reported a position in VRTX in Q3 2013 and has held it in 50 quarters since. The position peaked at $9.11M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Kentucky Retirement Systems held 19,299 shares of Vertex Pharmaceuticals worth $1.43M as of Q1 2026.
  • Kentucky Retirement Systems bought 3,152 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.47M.
  • Vertex Pharmaceuticals made up 0.11% of Kentucky Retirement Systems's portfolio in Q1 2026, its #220 holding.
  • Kentucky Retirement Systems first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
  • Kentucky Retirement Systems's Vertex Pharmaceuticals position peaked at $9.11M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Kentucky Retirement Systems's 13F filing for Q1 2026, filed 19 May 2026.